# Epirubicin

## Epicin 10mg/5mL

| TAH Drug Code      | [IEP10](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IEP10)                                                                                                                                                                                                                                                                                |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Breast cancer， malignant lymphoma， soft tissue sarcoma， stomach cancer， lung cancer， ovarian tumors.                                                                                                                                                                                                                                             |
| Dosing             | (仿單) Epirubicin should be administered intravenously or intravesicularly. Do not administer epirubicin orally， intramuscularly or subcutaneously. A lifetime maximum cumulative dose >1000 mg/m2 should be avoided. Usual dose: 75-90 mg/m2 intravenously once every 3 weeks. Intravesicular: 50 mg once weekly for 8 weeks; dose range: 30-80 mg. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | Myelosuppression. Cardiac impairment. Previous full cumulative doses of anthracyclines. Pregnancy. Lactation.                                                                                                                                                                                                                                         |
| Adverse Effects    | Myelosuppression， cardiotoxicity， alopecia， mucositis， GI disturbances， hyperpyrexia.                                                                                                                                                                                                                                                            |
| Pregnancy          | Contraindicated – 1st Trimester                                                                                                                                                                                                                                                                                                                       |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                       |
| More Info          | [UpToDate](https://www.uptodate.com/contents/epirubicin-drug-information)                                                                                                                                                                                                                                                                             |

## EPICIN 50mg/25mL

| TAH Drug Code      | [IEP50](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IEP50)                                                                                                                                                                                                                                                                                |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Breast cancer， malignant lymphoma， soft tissue sarcoma， stomach cancer， lung cancer， ovarian tumors.                                                                                                                                                                                                                                             |
| Dosing             | (仿單) Epirubicin should be administered intravenously or intravesicularly. Do not administer epirubicin orally， intramuscularly or subcutaneously. A lifetime maximum cumulative dose >1000 mg/m2 should be avoided. Usual dose: 75-90 mg/m2 intravenously once every 3 weeks. Intravesicular: 50 mg once weekly for 8 weeks; dose range: 30-80 mg. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | Myelosuppression. Cardiac impairment. Previous full cumulative doses of anthracyclines. Pregnancy. Lactation.                                                                                                                                                                                                                                         |
| Adverse Effects    | Myelosuppression， cardiotoxicity， alopecia， mucositis， GI disturbances， hyperpyrexia.                                                                                                                                                                                                                                                            |
| Pregnancy          | Contraindicated – 1st Trimester                                                                                                                                                                                                                                                                                                                       |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                       |
| More Info          | [UpToDate](https://www.uptodate.com/contents/epirubicin-drug-information)                                                                                                                                                                                                                                                                             |

